Real Chemistry Acquires Spring & Bond

Real Chemistry, a leader in data-driven healthcare marketing and communications, has acquired Spring & Bond, a boutique digital media agency specializing in omnichannel healthcare strategy. The move expands Real Chemistry’s media activation capabilities and adds to its positioning as a full-service partner for pharmaceutical and life sciences brands.

Expanding Omnichannel Capabilities

Founded and led by Elizabeth Beringer, Spring & Bond has built a reputation for precision media planning and activation across regulated healthcare environments. Its expertise spans audience segmentation, compliance-aligned programmatic, and ROI-driven optimization – capabilities that now sit at the core of Real Chemistry’s evolving media proposition.

The acquisition follows a series of moves by Real Chemistry to deepen its omnichannel offer, including its integration of Greater Than One earlier this year. Together, these additions aim to create a bridge between insight, content, and activation for healthcare clients seeking measurable impact.

Why It Matters for Pharma Media

For the pharmaceutical sector, the acquisition reflects an ongoing trend:

• Consolidation of expertise — agencies are merging data, media, and creative functions to simplify execution and speed delivery.

• Accountability and transparency — with campaigns under increasing compliance and ROI scrutiny, the ability to measure every impression and interaction is becoming a competitive differentiator.

• Regulated-ready innovation — integrating AI, automation, and programmatic workflows within a compliant framework is a key focus for safe healthcare marketing of the future.

Real Chemistry’s integrated model could help streamline campaign planning and improve efficiency—but it will also test how well large networks can maintain the agility and specialization that pharma clients demand.

solli‘s final thoughts

The acquisition of Spring & Bond underscores a growing industry movement toward true interconnectivity in pharma marketing — where success depends on seamless collaboration across creative, communications, medical affairs, and media. Increasingly, custom teams are being built around client needs, breaking down traditional silos to deliver integrated solutions that move from insight to activation with precision and compliance.

For Real Chemistry, this marks another step in recognizing media’s evolving role — not only as a high-performing, margin-accretive discipline in its own right, but as a critical integrator across the broader marketing mix. Its series of acquisitions this year reflects a deliberate investment in media’s connective power: the ability to unify data, content, and channel strategy to drive both performance and partnership wins.

The real test will be how effectively these interconnected models deliver on their promise — translating theoretical structural integration into smarter, faster, and more impactful outcomes for pharma clients.

Read the full press release HERE